Irbesartan and Aliskiren Interaction

Drug interaction information between Irbesartan and Aliskiren.

Irbesartan and Aliskiren have a documented major interaction in FDA labeling.

FDA drug labeling documents a major-severity interaction between Irbesartan and Aliskiren. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Irbesartan

Angiotensin II Receptor Blocker (ARB)

Drug B

Aliskiren

Direct Renin Inhibitor

How They Interact

These drugs both work on the same system in the body, which can lead to dangerously low blood pressure or kidney failure.

FDA Label Information

7.4 Dual Blockade of the Renin-Angiotensin System (RAS) Dual blockade of the RAS with angiotensin receptor blockers, ACE inhibitors, or aliskiren is associated with increased risks of hypotension, hyperkalemia, and changes in renal function (including acute renal failure) compared to monotherapy. Do not coadminister aliskiren with irbesartan tablets in patients with diabetes. Avoid use of aliskiren with irbesartan tablets in patients with renal impairment (GFR <60 mL/min).

Irbesartan Also Interacts With

View all Irbesartan interactions →

Frequently Asked Questions

What SPL severity band is on file for Irbesartan + Aliskiren?

Compiled FDA labeling labels this pair major. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Aliskiren has 28 labeled pairs on file vs Irbesartan's 2. In the major band specifically: Irbesartan has 1; Aliskiren has 22 (also Amlodipine/Benazepril, Amlodipine/Valsartan, Azilsartan, Benazepril).

What mechanism field is on file for Irbesartan and Aliskiren?

These drugs both work on the same system in the body, which can lead to dangerously low blood pressure or kidney failure.

Aliskiren carries more major-labeled pairs than Irbesartan

SPL source-record counts only. This page's band is major · classes on file: Irbesartan (Angiotensin II Receptor Blocker (ARB)); Aliskiren (Direct Renin Inhibitor).

Aliskiren has 22 major-labeled pairs vs Irbesartan's 1.

Irbesartan

1 major · 1 moderate · 0 minor · 2 total

Irbesartan has no other major-band peer in this dataset besides Aliskiren.

Aliskiren

22 major · 3 moderate · 3 minor · 28 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.